What Neopharma Technologies does

Neopharma Technologies is a Perth, Australia-based SaaS company that provides a digital Fit-for-Duty platform combining workplace drug and alcohol testing with cognitive and psychomotor impairment screening for safety-critical industries. The company targets organizations in mining, resources, ports, marine, and aviation ground operations where contractor-heavy workforces and multi-site deployments require consistent, documented impairment risk management. Its customer base spans direct enterprise accounts, third-party administrators (TPAs), drug testing device distributors, and testing device manufacturers served through an OEM channel model.

The core product, NEOVAULT, is a device-agnostic point-of-care platform that captures drug and alcohol test results through smartphone or tablet applications and produces digital chain-of-custody records and audit-ready compliance documentation. The platform incorporates NEO-Vision computer vision technology for automated interpretation of oral fluid, urine, and breath alcohol test results, and integrates with DRUID, a one-minute functional impairment assessment that compares cognitive and psychomotor performance against individual personal baselines. The NEOTEST product range includes purpose-built hardware (Tamperloks, Split Cups, Multi-Panel Cups, Dip Cards, Oral Fluid tests) that operate natively within the NEOVAULT ecosystem. The platform holds ISO 27001, SOC 2 Type II, HIPAA, and GDPR certifications and integrates with EHS platforms including HSI Donesafe via API.

Neopharma operates a multi-revenue-stream model combining SaaS subscriptions (NEOVAULT/DRUID enterprise licensing) with hardware sales (NEOTEST kits) and OEM/API distribution through EHS platform and device-manufacturer partners. The go-to-market is enterprise-focused with quote-based pricing, direct field sales, and an API-first channel strategy. The company maintains offices in Perth (headquarters), Utah (USA), and Kuala Lumpur (Malaysia), with operational footprint across Australia, the United States, Canada, and Malaysia. The company is pursuing a NASDAQ listing as of late 2025, with Singapore fintech veteran Joo Seng Wong appointed as Board Advisor to oversee institutional strategy and global execution.

Name

Neopharma Technologies

Legal name

Neopharma Technologies

Website

https://neopharmatechnologies.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Neopharma Technologies provides a SaaS platform combining workplace drug and alcohol testing with AI-driven cognitive impairment screening for safety-critical industries including mining, ports, and aviation. The Perth-based company serves enterprises and channel partners across Australia, the US, and Southeast Asia.

Ownership category

akta.pro rank

Headquarters

HQ city

Perth

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscription: Cloud-based platform subscription for access to NEOVAULT and DRUID software. Includes dashboard access, API integrations, workflow management, and reporting capabilities. Subscription tiers likely based on organization size, number of sites, and feature requirements.
2. NEOTEST Testing Kits: Sale of NEOTEST branded drug and alcohol testing devices including oral fluid tests, urine cups, dip cards, split cups, and Tamperloks devices. Devices are sold as NEOVAULT-enabled units with integrated software capability.
3. Enterprise Licensing: Enterprise licensing for large multi-site organizations requiring standardized Fit-for-Duty workflows across multiple locations and contractor groups. Includes configuration, integration, and deployment services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Neopharma Technologies develops and sells NEOVAULT®, a device-agnostic point-of-care SaaS platform that integrates drug and alcohol testing with cognitive and psychomotor impairment screening for enterprise Fit-for-Duty workforce management. The platform combines AI-powered automated result interpretation (NEO-Vision), digital chain of custody, and multi-site enterprise scalability. It is complemented by the DRUID® impairment screening module and the NEOTEST® range of physical testing devices (oral fluid, urine cups, dip cards, split cups, Tamperloks) designed to operate natively within the NEOVAULT ecosystem.

Product overview

Neopharma Technologies offers NEOVAULT®, a device-agnostic point-of-care platform that integrates drug and alcohol testing with cognitive and psychomotor impairment screening into a unified Fit-for-Duty solution. The core NEOVAULT® platform is supported by add-on modules including NEO-Vision (AI image recognition for automated result interpretation), Digital Chain of Custody, Fit-for-Duty Decisioning, Enterprise Scalability, Compliance and Governance, BrAC Recording, and Digital Drug Testing workflows. The companion DRUID® module provides one-minute functional impairment assessment measuring cognitive and psychomotor performance against individual baselines. The NEOTEST® product family includes purpose-built testing devices (Tamperloks, Split Cups, Multi-Panel Cups, Dip Cards, Oral Fluid tests) that are NEOVAULT®-enabled out of the box. The combined NEOVAULT® + DRUID® ecosystem delivers comprehensive workforce impairment management for safety-critical environments.

Differentiator

Problem solved

Functional benefit

Brands

• NEOVAULT: Digital drug testing and chain of custody platform for workplace fit-for-duty assessment
• DRUID
• NEOTEST
• NEO-Vision

Products and services

• NEOVAULT® Device-agnostic point-of-care SaaS platform that integrates drug and alcohol testing with cognitive and psychomotor impairment screening. Uses a smartphone or tablet app to capture and process test results in real time, creating a defensible digital audit trail with automated chain of custody, escalation rules, and compliance governance for enterprise workforce Fit-for-Duty programs.
• DRUID® Impairment Screening One-minute functional impairment assessment delivered via smartphone or tablet. Measures cognitive and psychomotor performance (reaction time, processing speed, hand-eye coordination, balance, short-term processing capacity) against individual personal baselines to detect impairment from fatigue, illness, stress, medication, or substances. Each worker establishes a personal baseline through three supervised practice tests.
• Tamperloks Drug Testing Cup Tamper-proof urine drug testing cup with interlocking lid and seal, unique triple chamber design that is 100% leak and odor proof. Includes temperature test strip and adulteration detection. Digitally enabled via NEOVAULT app with dynamic QR code and electronic chain of custody integration.
• Drug Test Split Cup Dual specimen chamber urine test cup that simultaneously screens for up to 7 drugs and retains specimens for confirmation testing. Features leak-resistant hinged lid, angled opening, and specimen temperature indication with qualitative results in 5 minutes.
• Multi Panel Drug Test Cups All-in-one urine-based multi-drug test cup supporting 1 to 14 panels per specifications. Quick, precise solution for on-site drug screening with results in minutes. FDA cleared and CLIA waived.
• Dip Card Drug Tests CLIA Waived and FDA 510(k) cleared all-in-one urine-based drug test in dip card format. Supports 1 to 6 panels with simple non-invasive procedure and fast results in 5 minutes. Complies with AS/NZS 4308:2008 Australian Standard.
• Drug Test Oral Fluid Oral fluid drug test complying with AS4760:2019 Australian Standard. Simple, fast, accurate detection of recent illicit drug use. Supports 1 to 14 panels and detects commonly abused drugs at concentrations below 75 ng/mL with non-invasive sample collection.

Quantifiable outcome

• Complete digital chain of custody, eliminating paper-based documentation
• +3 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• HSI DonesafecoreTechnology or Integration · 24 February 2026API integration embedding Neopharma's NEOVAULT Fit-For-Duty workflows and DRUID impairment assessment into HSI Donesafe's cloud-based EHS safety management platform. The integration consolidates drug and alcohol testing and functional impairment assessments within the same governance system used for safety reporting, replacing fragmented checks with connected controls and strengthening audit trails. Addresses Australian WHS regulatory requirements.
• Impairment SciencecoreTechnology or Integration · 1 February 2025Partnership to integrate NEOVAULT digital drug test reporting with AI-powered cognitive impairment assessment tools. Combines Neopharma's drug and alcohol testing platform with Impairment Science's cognitive assessment capabilities for comprehensive Fit-for-Duty screening.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Dräger: German multinational manufacturer of safety and medical technology, including the DrugTest 5000 oral fluid drug testing system and Alcotest breath alcohol devices used in workplace and law enforcement settings. Directly comparable in workplace drug and alcohol testing hardware, with Dräger operating as a much larger incumbent across broader industrial safety.
• Abbott Toxicology: Global diagnostics and medical device company with significant workplace drug testing operations through its eScreen and Alere Toxicology platforms. Comparable enterprise SaaS and drug testing offering but with a much broader diagnostics and device portfolio.
• Quest Diagnostics: Major US medical laboratory services company with substantial employer solutions and workplace drug testing services. Comparable substance testing services but at much larger scale and with broader clinical and anatomic pathology focus.

Emerging players

• Soberlink: Remote alcohol monitoring device and cloud platform used in legal, employment, and recovery contexts. Comparable digital impairment monitoring technology with similar enterprise and B2B workplace applications, though narrower in scope to alcohol rather than full substance and cognitive screening.

Direct peers

• Omega Laboratories: Specialized drug testing laboratory offering hair, urine, and oral fluid testing for workplace, legal, and clinical markets. Comparable substance testing focus with similar turnaround-time and chain-of-custody requirements.
• OraSure Technologies: Manufacturer of oral fluid diagnostic products including the Intercept drug testing device used in workplace and clinical settings. Directly comparable in vitro diagnostic substance manufacturing focused on oral fluid drug detection and workplace testing applications.
• Psychemedics: Specialized hair drug testing laboratory providing workplace drug testing services to employers. Comparable substance testing focus with an alternative sample type and similar employer-customer profile.
• SureHire: Canadian workplace drug and alcohol testing service provider offering fitness-for-duty assessments for employers across industrial sectors. Directly comparable employer-focused drug and impairment testing offering, primarily serving the Canadian market.
• Cordant Health Solutions: Workplace drug testing and behavioral health services provider offering substance testing, medication monitoring, and behavioral health programs for employers and the justice system. Comparable employer drug testing services with overlapping customer base in safety-sensitive industries.
• Premier Biotech: US-based manufacturer of urine and oral fluid drug testing devices, including multi-panel cups and dip cards used at point of care. Directly comparable drug testing device manufacturing with focus on workplace and clinical point-of-care products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neopharma Technologies